Serotonin antagonism and serotonin antagonists in pregnancy: Role of ketanserin

Obstetrical and Gynecological Survey

Volumn 55, Issue 9, 2000, Pages 582-589

  Steyn, D W ^a,b   Odendaal, H J ^a  

^a STELLENBOSCH UNIVERSITY   (South Africa)

^b NONE   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; DIHYDRALAZINE; KETANSERIN; METHYLDOPA; SEROTONIN 2 ANTAGONIST; SEROTONIN ANTAGONIST;

DIASTOLIC BLOOD PRESSURE; DRUG EFFICACY; DRUG POTENTIATION; HELLP SYNDROME; HYPERTENSION; MATERNAL HYPERTENSION; PERINATAL MORTALITY; PREECLAMPSIA; PREGNANCY; REVIEW; SOLUTIO PLACENTAE; SYSTOLIC BLOOD PRESSURE;

ADULT; ANTIHYPERTENSIVE AGENTS; CLINICAL TRIALS; FEMALE; HUMANS; HYPERTENSION; KETANSERIN; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; SEROTONIN ANTAGONISTS;

EID: 0033840413     PISSN: 00297828     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006254-200009000-00024     Document Type: Review

References (70)

1. Report on high blood pressure in pregnancy
2. Management of hypertension in pregnancy: Executive summary
3. Hypertension in pregnancy
4. Hypertension
5. Pharmacological prevention and treatment of hypertensive disorders in pregnancy
6. Treatment of hypertension in pregnant women
7. Management of severe hypertension in pregnancy/eclampsia in Africa
8. A comparative trial of labetalol and hydralazine in the acute management of severe hypertension complicating pregnancy
9. The effect of low-dose dihydralazine on the fetus in the emergency treatment of hypertension in pregnancy
10. Hemodynamics in hypertensive pregnancies
11. Ketanserin - A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in hypertension and peripheral vascular disease
12. Serotonin and serotonin antagonism in cardiovascular and non-cardiovascular disease
13. Platelet poor plasma serotonin in normal and preeclamptic pregnancy
14. Recent developments in the physiology and pharmacology of 5-hydroxytryptamine
15. Platelet-endothelial interactions
16. 5-Hydroxytryptamine (serotonin) receptor agonists and antagonists
17. Pathogenesis of preeclampsia: A hypothesis
18. VII International Union of Pharmacology classification of receptors for 5-hydroxytryptamine
19. Serotonin
20. Endothelial dysfunction in preeclampsia. Part II: Reducing the adverse consequences of endothelial cell dysfunction in preeclampsia: Therapeutic perspectives
21. 2 receptor antagonist
22. A comparative and long term evaluation of ketanserin in the treatment of essential hypertension
23. Clinical experience with ketanserin in the treatment of hypertension
24. Ketanserin versus metoprolol in the treatment of essential hypertension
25. Double-blind comparison of ketanserin and propranolol in hypertensive patients
26. Double blind comparison on ketanserin with atenolol: Antihypertensive activity and effect on platelet function
27. Serotonergic blockade compared with beta adrenergic blockade in systemic hypertension. A double-blind comparison of ketanserin with propranolol
28. Comparison of ketanserin and captopril in older hypertensives. A double-blind randomised trial
29. Comparison of ketanserin and enalapril in the treatment of mild to moderate essential hypertension
30. Ketanserin versus metoprolol and hydrochlorothiazide in essential hypertension: Only ketanserin's hypotensive effect is age-related
31. Comparative study of ketanserin and hydrochlorothiazide in essential hypertension
32. Ketanserin compared to nifedipine and methyldopa in patients aged above 50 years. Two international multicentre studies
33. Evaluation of a new antihypertensive agent ketanserin versus methyldopa in the treatment of essential hypertension in older patients. An international multicentre trial
34. Ketanserin and prazosin. A comparison of antihypertensive and biochemical effects
35. Metabolic aspects of antihypertensive treatment with ketanserin
36. 2-serotonergic antagonist, ketanserin
37. Acute blood pressure lowering effect of ketanserin
38. Ketanserin in the acute management of severe hypertension
39. Hemodynamic effects of ketanserin, a selective 5-hydroxytryptamine (serotonin) receptor antagonist, on essential hypertension
40. Serotonin and hypertension
41. Haemodynamic and humoral responses to chronic ketanserin treatment in essential hypertension
42. 2 serotonergic receptors during chronic administration of ketanserin in humans
43. Continuous inhibition of serotonin-induced platelet aggregation during chronic ketanserin administration to man can be detected after plasma pH control
44. Serotonin and vascular smooth muscle
45. Mechanism of anti-hypertensive action of ketanserin in man
46. Acute and chronic ketanserin in essential hypertension: Anti-hypertensive mechanism and pharmacokinetics
47. Alpha-adrenergic blockade makes minimal contribution to ketanserin's hypotensive effect
48. 2) antagonists: A novel class of cardiovascular drugs
49. 2-serotonergic receptor blockade
50. Chronic effects of serotonin inhibition in hypertensive patients: Hemodynamic and humoral findings
51. Effects of ketanserin on cardiovascular, sympatho-adrenal and endocrine systems during physical exercise in man
52. 2 antagonists on transmembrane cation transport systems
53. Second line therapy with ketanserin in severe early-onset preeclampsia
54. Intrapartum treatment of preeclamptic hypertension by ketanserin - A serotonin receptor antagonist
55. Control of preeclamptic hypertension by ketanserin, a new serotonin receptor antagonist
56. The effect of serotonergic blockade in postpartum preeclamptic patients
57. Intrapartum treatment of preeclamptic hypertension by ketanserin
58. Orale ketanserien vir die behandeling van preeclampsia
59. Pathophysiology of preeclampsia and fetal outcome
60. Ketanserin and hydralazine in hypertension in pregnancy - A randomised double-blind trial
61. Dihydralazine or ketanserin for severe hypertension in pregnancy? Preliminary results
62. Comparison of the effectivity and safety of ketanserin versus dihydralazine in the treatment of severe preeclampsia
63. The haemodynamic effects of ketanserin versus dihydralazine in severe early-onset hypertension in pregnancy
64. Ketanserin Versus dihydralazine in the management of severe early-onset preeclampsia: Maternal outcome
65. Ketanserin in the treatment of chronic and preeclamptic hypertensive pregnant women
66. Ketanserin, S2 receptor antagonist, in the treatment of hypertension in pregnancy
67. Ricerca Scientifica ed Educazione Permanente
68. Ketanserin versus alpha-methyldopa in the treatment of hypertension during pregnancy: A preliminary report
69. Ketanserin, a 5-HTA2 serotonergic receptor antagonist, could be useful in the HELPP syndrome
70. Ketanserin and aspirin in the prevention of preeclampsia - A randomised controlled trial